Dexamethasone treatment during the expansion phase maintains stemness of bone marrow mesenchymal stem cells.
about
Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?In vitro effects of RU486 on proliferation and differentiation capabilities of human bone marrow mesenchymal stromal cells.In vivo formation of bone and haematopoietic territories by transplanted human bone marrow stromal cells generated in medium with and without osteogenic supplements.Sika Deer Antler Collagen Type I-Accelerated Osteogenesis in Bone Marrow Mesenchymal Stem Cells via the Smad Pathway.Glucocorticoid Cell Priming Enhances Transfection Outcomes in Adult Human Mesenchymal Stem Cells.Enhancement of Matrix Metalloproteinase-2 (MMP-2) as a Potential Chondrogenic Marker during Chondrogenic Differentiation of Human Adipose-Derived Stem CellsPyrintegrin Induces Soft Tissue Formation by Transplanted or Endogenous Cells.Osteogenic stimulatory conditions enhance growth and maturation of endothelial cell microvascular networks in culture with mesenchymal stem cells.Effect of hydrocortisone on multipotent human mesenchymal stromal cells.Comparative study of in vitro expansion of bone marrow-derived mesenchymal stem cells.MicroRNA‑218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15‑hydroxyprostaglandin dehydrogenase [NAD(+)].Simvastatin induces osteogenic differentiation in human amniotic fluid mesenchymal stem cells (AFMSC).The neural plasticity of early-passage human bone marrow-derived mesenchymal stem cells and their modulation with chromatin-modifying agents.Effects of Passage Number and Differentiation Protocol on the Generation of Dopaminergic Neurons from Rat Bone Marrow-Derived Mesenchymal Stem Cells.
P2860
Q26766574-DB98C69C-8E1A-4C03-8352-6775D7C8E8CAQ35624319-8519714D-9E39-4EEE-AC60-030CEBCF1F9DQ35748617-BAFD6299-2EE8-4FB7-9FCD-4BAD097D5AA1Q36732927-5E2915BE-9389-47C5-9FD2-6FA47006CDB8Q36756853-6F1D4F29-A2C9-45CA-8309-2AC872FDCA6BQ37050849-3D9650D0-E385-450E-B514-2493BC5632B1Q37609271-61AA369D-F6C4-4E30-98B1-E81493C88B4CQ41861726-46BF683A-0668-4F2E-B892-D60D4F7C88C5Q43419638-B8C85C66-0F4B-4C98-9336-38595234F7CDQ43434403-3FE5B4C8-E081-4F23-AB62-71974EAA7771Q47437884-134565C3-7CD4-4E2C-BE8D-F1C74BC41D3FQ50501458-174D4F48-4221-455E-801C-E8417175375BQ50576354-FE170B0D-DCDC-408C-8A46-6CA914313744Q54967971-1625CF1E-37A4-4580-807C-BF16E3FC8DEE
P2860
Dexamethasone treatment during the expansion phase maintains stemness of bone marrow mesenchymal stem cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Dexamethasone treatment during ...... marrow mesenchymal stem cells.
@en
Dexamethasone treatment during ...... marrow mesenchymal stem cells.
@nl
type
label
Dexamethasone treatment during ...... marrow mesenchymal stem cells.
@en
Dexamethasone treatment during ...... marrow mesenchymal stem cells.
@nl
prefLabel
Dexamethasone treatment during ...... marrow mesenchymal stem cells.
@en
Dexamethasone treatment during ...... marrow mesenchymal stem cells.
@nl
P2093
P356
P1476
Dexamethasone treatment during ...... marrow mesenchymal stem cells.
@en
P2093
Jannie Borst
Joost D de Bruijn
Linda van Rijn
Victor Peperzak
Yanling Xiao
P304
P356
10.1002/TERM.250
P577
2010-07-01T00:00:00Z